|
1
|
Takeda N, Manabe I, Uchino Y, Eguchi K,
Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P,
Conway SJ and Nagai R: Cardiac fibroblasts are essential for the
adaptive response of the murine heart to pressure overload. J Clin
Invest. 120:254–265. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Porter KE and Turner NA: Cardiac
fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther.
123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ren J, Yang M, Qi G, Zheng J, Jia L, Cheng
J, Tian C, Li H, Lin X and Du J: Proinflammatory protein CARD9 is
essential for infiltration of monocytic fibroblast precursors and
cardiac fibrosis caused by Angiotensin II infusion. Am J Hypertens.
24:701–707. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang XR, Chung AC, Yang F, Yue W, Deng C,
Lau CP, Tse HF and Lan HY: Smad3 mediates cardiac inflammation and
fibrosis in angiotensin II-induced hypertensive cardiac remodeling.
Hypertension. 55:1165–1171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olson ER, Shamhart PE, Naugle JE and
Meszaros JG: Angiotensin II-induced extracellular signal-regulated
kinase 1/2 activation is mediated by protein kinase Cdelta and
intracellular calcium in adult rat cardiac fibroblasts.
Hypertension. 51:704–711. 2008. View Article : Google Scholar
|
|
6
|
Schellings MW, Vanhoutte D, van Almen GC,
Swinnen M, Leenders JJ, Kubben N, van Leeuwen RE, Hofstra L,
Heymans S and Pinto YM: Syndecan-1 amplifies angiotensin II-induced
cardiac fibrosis. Hypertension. 55:249–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lijnen PJ, Van Pelt JF and Fagard RH:
Stimulation of reactive oxygen species and collagen synthesis by
angiotensin II in cardiac fibroblasts. Cardiovasc Ther. 30:e1–e8.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang P, Su J, King ME, Maldonado AE, Park
C and Mende U: Regulator of G protein signaling 2 is a functionally
important negative regulator of angiotensin II-induced cardiac
fibroblast responses. Am J Physiol Heart Circ Physiol.
301:H147–H156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang X, Tsitsiou E, Herrick SE and
Lindsay MA: MicroRNAs and the regulation of fibrosis. FEBS J.
277:2015–2021. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diez J: Do microRNAs regulate myocardial
fibrosis? Nat Clin Pract Cardiovasc Med. 6:88–89. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thum T, Gross C, Fiedler J, Fischer T,
Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et
al: MicroRNA-21 contributes to myocardial disease by stimulating
MAP kinase signalling in fibroblasts. Nature. 456:980–984. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008.PubMed/NCBI
|
|
14
|
Duisters RF, Tijsen AJ, Schroen B, et al:
miR-133 and miR-30 regulate connective tissue growth factor:
implications for a role of microRNAs in myocardial matrix
remodeling. Circ Res. 104:170–178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai
B, Wang N, Li X, Feng T, Hong Y and Yang B: Downregulation of
miR-133 and miR-590 contributes to nicotine-induced atrial
remodelling in canines. Cardiovasc Res. 83:465–472. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Limana F, Esposito G, D’Arcangelo D, Di
Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G,
Germani A and Capogrossi MC: HMGB1 attenuates cardiac remodelling
in the failing heart via enhanced cardiac regeneration and
miR-206-mediated inhibition of TIMP-3. PLoS One. 6:e198452011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Huang W, Xu R, Nie Y, Cao X, Meng
J, Xu X, Hu S and Zheng Z: MicroRNA-24 regulates cardiac fibrosis
after myocardial infarction. J Cell Mol Med. 16:2150–2160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Patrick DM, Montgomery RL, Qi X, Obad S,
Kauppinen S, Hill JA, et al: Stress-dependent cardiac remodeling
occurs in the absence of microRNA-21 in mice. J Clin Invest.
120:3912–3916. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang H, Zhang C, Ban T, Liu Y, Mei L,
Piao X, Zhao D, Lu Y, Chu W and Yang B: A novel reciprocal loop
between microRNA-21 and TGFβRIII is involved in cardiac fibrosis.
Int J Biochem Cell Biol. 44:2152–2160. 2012.PubMed/NCBI
|
|
20
|
Jiang X, Ning Q and Wang J: Angiotensin II
induced differentially expressed microRNAs in adult rat cardiac
fibroblasts. J Physiol Sci. 63:31–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang
Y, Tantoso E, Li KB, Ooi LL, Tan P and Lee CG: Profiling microRNA
expression in hepatocellular carcinoma reveals microRNA-224
up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific
target. J Biol Chem. 283:13205–13215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Toh HC, Chow P, Chung AY, Meyers
DJ, Cole PA, Ooi LL and Lee CG: MicroRNA-224 is up-regulated in
hepatocellular carcinoma through epigenetic mechanisms. FASEB J.
26:3032–3041. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao G, Yin M, Lian J, Tian H, Liu L, Li X
and Sun F: MicroRNA-224 is involved in transforming growth
factor-β-mediated mouse granulosa cell proliferation and granulosa
cell function by targeting Smad4. Mol Endocrinol. 24:540–551.
2010.
|
|
24
|
Liang M, Yao G, Yin M, Lu M, Tian H, Liu
L, Lian J, Huang X and Sun F: Transcriptional cooperation between
p53 and NF-κB p65 regulates microRNA-224 transcription in mouse
ovarian granulosa cells. Mol Cell Endocrinol. 370:119–129.
2013.
|
|
25
|
Li Q, Wang G, Shan JL, Yang ZX, Wang HZ,
Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, Luo XZ and Wang D:
MicroRNA-224 is upregulated in HepG2 cells and involved in cellular
migration and invasion. J Gastroenterol Hepatol. 25:164–171. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang L, Dai T, Lin X, Zhao X, Chen X,
Wang C, Li X, Shen H and Wang X: MicroRNA-224 targets RKIP to
control cell invasion and expression of metastasis genes in human
breast cancer cells. Biochem Biophys Res Commun. 425:127–133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Takahashi S, Tasaka A, Yoshima T,
Ochi H and Chayama K: Involvement of microRNA-224 in cell
proliferation, migration, invasion, and anti-apoptosis in
hepatocellular carcinoma. J Gastroenterol Hepatol. 28:565–575.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Olaru AV, Yamanaka S, Vazquez C, Mori Y,
Cheng Y, Abraham JM, Bayless TM, Harpaz N, Selaru FM and Meltzer
SJ: MicroRNA-224 negatively regulates p21 expression during late
neoplastic progression in inflammatory bowel disease. Inflamm Bowel
Dis. 19:471–480. 2013. View Article : Google Scholar : PubMed/NCBI
|
